Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Glioma 6Glioblastoma 3Insulinoma 2Hypoglycemia 2Hyperinsulinism 2Congenital Hyperinsulinism 2Brain Neoplasms 2Sarcoma 1Pheochromocytoma 1Parkinsonian Disorders 1Parkinson Disease 1Oligodendroglioma 1Neuroendocrine Tumors 1Neuroblastoma 1Neoplasms 1Lewy Body Disease 1Infant, Newborn, Diseases 1Glucose Metabolism Disorders 1Gliosarcoma 1Glioma, Subependymal 1Ependymoma 1Endocrine System Diseases 1Carcinoma, Medullary 1Carcinoid Tumor 1Beckwith-Wiedemann Syndrome 1Astrocytoma 1

Interventions

Magnetic Resonance Spectroscopy 9Cyclophosphamide 7X-Rays 6Temozolomide 6Specimen Handling 6Phantoms, Imaging 6Biopsy 6Nuclear Medicine Department, Hospital 5Etoposide 5Nivolumab 4Bevacizumab 4Radiation 3Irinotecan 3Automobiles 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2lutetium Lu 177 dotatate 2larotrectinib 2ivosidenib 2etoposide phosphate 2erdafitinib 2ensartinib 2abemaciclib 2Watchful Waiting 2Radiotherapy 2ONC206 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ependymoma × fluorodopa F 18 × 1 year × Clear all
NCT01165632 2025-09-02

Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma

Mayo Clinic

Phase EARLY_PHASE1 Completed
24 enrolled
CNSSarcoma

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡